Fractyl Health Set to Present at Key Investor Conferences
Fractyl Health Set to Present at Key Investor Conferences
Fractyl Health, Inc. (Nasdaq: GUTS), a pioneering company in metabolic therapeutics, is dedicated to addressing the root causes of obesity and Type 2 Diabetes (T2D). Co-founder and CEO, Harith Rajagopalan, M.D., Ph.D., is scheduled to make notable presentations at two upcoming investor conferences, furthering the company's mission to develop impactful treatments.
Upcoming Conference Details
Fractyl Health will showcase its innovative approaches through presentations at the following conferences:
Morgan Stanley Global Healthcare Conference
This event will feature a fireside chat format, allowing for an engaging dialogue about the future of metabolic therapeutics.
Date: September 6, 2024
Time: 10:45 AM ET
H.C. Wainwright 26th Annual Global Investment Conference
Following this, Fractyl's leadership will present in a formal company presentation setting, discussing advancements and future plans.
Date: September 9, 2024
Time: 2:00 PM ET
Accessing Conference Replays
Interested parties can catch up on both presentations through webcast replays that will be available on the Events page of the Investor section at Fractyl Health’s website.
About Fractyl Health
Fractyl Health is on the forefront of metabolic therapeutics, striving to enhance the treatment landscape for metabolic diseases, including obesity and T2D. Despite significant progress in the last few decades, these conditions remain prevalent, posing serious health risks. Fractyl Health aims to transition the focus from merely managing symptoms to developing durable, disease-modifying therapies that address the underlying causes.
Based in Burlington, MA, Fractyl Health generates innovative solutions to help those suffering from metabolic diseases and improve overall health outcomes.
Contacts
Corporate Contact
Lisa Davidson, Chief Financial Officer
Email: ir@fractyl.com, Phone: 781.902.8800
Media Contact
Jessica Cotrone, Corporate Communications
Email: jcotrone@fractyl.com, Phone: 978.760.5622
Investor Contact
Stephen Jasper, Gilmartin Group
Email: stephen@gilmartinir.com, Phone: 619.949.3681
Frequently Asked Questions
What is Fractyl Health known for?
Fractyl Health is a leader in metabolic therapeutics, focusing on innovative treatments for obesity and Type 2 Diabetes.
When is the next investor conference for Fractyl Health?
The next investor conference is the Morgan Stanley Global Healthcare Conference on September 6, 2024.
How can I watch the presentations from the investor conferences?
Webcast replays of the conferences will be available on the Events page of Fractyl Health’s Investor section after the live sessions.
Who is the CEO of Fractyl Health?
Harith Rajagopalan, M.D., Ph.D., is the Co-founder and Chief Executive Officer of Fractyl Health.
What is the goal of Fractyl Health?
Fractyl Health aims to transition metabolic disease treatment to durable therapies that address root causes instead of just symptom management.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Plastic Caps and Closures Market Set to Reach USD 96.28 Billion
- Global PET-CT Scanner Market Set for $4.9 Billion Growth
- SS Innovations' First Mantra Surgical System Sale in Latin America
- Constellation Brands Revises Fiscal 2025 Financial Outlook
- RecycLiCo Battery Materials Appoints Dr. Maryam Rasouli as Principal Engineer
- Procaps Group Outlines Strategic Vision for Future Success
- GLOBO Language Solutions Explores AI in Medical Interpretation
- DemandScience Achieves a Historic 11th Inc. 5000 Honor
- Object Management Group Launches New Journal of Innovation
- Altamira Therapeutics Attends H.C. Wainwright Conference 2024
- Healthcare Mobility Solutions Market Foresees Major Growth
- Sustainable Apparel Market Projected to Hit USD 24.53 Billion
- Bio-Based Coatings Market Growth Driven by Eco-Friendly Demand
- Fleet Management Software Market Growth to USD 93.17 Billion
- Optical Modulators Market Growth Metrics and Key Drivers
- The Surging Mixed Reality Market: Predicted to Hit USD 76.91 Billion
- ChartPath and WoundZoom Partner to Revolutionize Wound Care
- Nutricosmetics Market Expected to Exceed $16.93 Billion Growth
- Affiliated Network Providers and Aurora Health Join Forces
- Ignitis Group Greenlights 174 MW Solar Project in Latvia
- Johnny Clark Welcomes EFFO: The Ultimate Frying Oil Solution
- Ignitis Group Commits to 174 MW Tume Solar Project
- Caristo Diagnostics Recognized as a Quarterfinalist for Digital Health Award
- INmune Bio Inc. Joins Baird 2024 Global Healthcare Conference
- Steward Healthcare Faces Bankruptcy Challenges Next Week
Recent Articles
- Object Management Group Launches New Journal of Innovation
- Sustainable Apparel Market Projected to Hit USD 24.53 Billion
- Steward Healthcare Faces Bankruptcy Challenges Next Week
- Bango Partners with Disney+ to Expand Subscriber Offerings
- ThreatHunter.ai Launches Free Cybersecurity Tool for Businesses
- Christian Lingua Earns Top Language Training Honor in Industry
- Roper Technologies to Showcase Innovations at GS Conference
- RDE, Inc. Changes Ticker Symbol to GIFT for Growth
- Pneumococcal Vaccine Market to Reach USD 14.78 Billion by 2034
- NMI Holdings, Inc. Investor Day Scheduled for November 2024
- TC BioPharm Expands Patient Dosing in ACHIEVE Clinical Trial
- Ruder Finn Appoints Zack Kass to Lead New AI Advisory Council
- Restaurant Brands International Inc. Launches Secure Notes Offering
- Innovative Insights from Cold Spring Harbor Laboratory's Research
- TopBuild CEO to Speak at Jefferies Industrials Conference
- Protalix BioTherapeutics Eliminates Debt with Note Repayment
- Grease Barrier Market Growth Projected at USD 1,483.1 Million
- Dyne Therapeutics Strengthens Leadership for Growth Ahead
- Importance of Blood Donations in Sickle Cell Treatments
- HSG Laser Celebrates Four Years of Innovation and Growth
- Investing in the Future: AI Stocks to Consider Now
- Vow ASA Insider Trading Update: Board Member Purchases Shares
- Copenhagen Airports A/S Projects Strong Growth for 2024
- Natural Catastrophe Losses Skyrocket to $151 Billion in 2024
- Exploring Promising Space Stocks for Future Growth